Literature DB >> 19389408

An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model.

Elena Harjes1, Phillip J Gross, Kuan-Ming Chen, Yongjian Lu, Keisuke Shindo, Roni Nowarski, John D Gross, Moshe Kotler, Reuben S Harris, Hiroshi Matsuo.   

Abstract

Human APOBEC3G (A3G) belongs to a family of polynucleotide cytidine deaminases. This family includes APOBEC1 and AID, which edit APOB mRNA and antibody gene DNA, respectively. A3G deaminates cytidines to uridines in single-strand DNA and inhibits the replication of human immunodeficiency virus-1, other retroviruses, and retrotransposons. Although the mechanism of A3G-catalyzed DNA deamination has been investigated genetically and biochemically, atomic details are just starting to emerge. Here, we compare the DNA cytidine deaminase activities and NMR structures of two A3G catalytic domain constructs. The longer A3G191-384 protein is considerably more active than the shorter A3G198-384 variant. The longer structure has an alpha1-helix (residues 201-206) that was not apparent in the shorter protein, and it contributes to catalytic activity through interactions with hydrophobic core structures (beta1, beta3, alpha5, and alpha6). Both A3G catalytic domain solution structures have a discontinuous beta2 region that is clearly different from the continuous beta2 strand of another family member, APOBEC2. In addition, the longer A3G191-384 structure revealed part of the N-terminal pseudo-catalytic domain, including the interdomain linker and some of the last alpha-helix. These structured residues (residues 191-196) enabled a novel full-length A3G model by providing physical overlap between the N-terminal pseudo-catalytic domain and the new C-terminal catalytic domain structure. Contrary to predictions, this structurally constrained model suggested that the two domains are tethered by structured residues and that the N- and C-terminal beta2 regions are too distant from each other to participate in this interaction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19389408      PMCID: PMC2700007          DOI: 10.1016/j.jmb.2009.04.031

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  47 in total

1.  Crystallography & NMR system: A new software suite for macromolecular structure determination.

Authors:  A T Brünger; P D Adams; G M Clore; W L DeLano; P Gros; R W Grosse-Kunstleve; J S Jiang; J Kuszewski; M Nilges; N S Pannu; R J Read; L M Rice; T Simonson; G L Warren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-09-01

2.  Increased sensitivity in HNCA and HN(CO)CA experiments by selective C beta decoupling.

Authors:  H Matsuo; E Kupce; H Li; G Wagner
Journal:  J Magn Reson B       Date:  1996-10

3.  The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells.

Authors:  J H Simon; R A Fouchier; T E Southerling; C B Guerra; C K Grant; M H Malim
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Protein backbone angle restraints from searching a database for chemical shift and sequence homology.

Authors:  G Cornilescu; F Delaglio; A Bax
Journal:  J Biomol NMR       Date:  1999-03       Impact factor: 2.835

5.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

Review 6.  The nucleoside deaminases for cytidine and adenosine: structure, transition state stabilization, mechanism, and evolution.

Authors:  C W Carter
Journal:  Biochimie       Date:  1995       Impact factor: 4.079

7.  Transition-state selectivity for a single hydroxyl group during catalysis by cytidine deaminase.

Authors:  S Xiang; S A Short; R Wolfenden; C W Carter
Journal:  Biochemistry       Date:  1995-04-11       Impact factor: 3.162

8.  Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications.

Authors:  Lauren G Holden; Courtney Prochnow; Y Paul Chang; Ronda Bransteitter; Linda Chelico; Udayaditya Sen; Raymond C Stevens; Myron F Goodman; Xiaojiang S Chen
Journal:  Nature       Date:  2008-10-12       Impact factor: 49.962

9.  Backbone 1H and 15N resonance assignments of the N-terminal SH3 domain of drk in folded and unfolded states using enhanced-sensitivity pulsed field gradient NMR techniques.

Authors:  O Zhang; L E Kay; J P Olivier; J D Forman-Kay
Journal:  J Biomol NMR       Date:  1994-11       Impact factor: 2.835

10.  A novel approach for sequential assignment of 1H, 13C, and 15N spectra of proteins: heteronuclear triple-resonance three-dimensional NMR spectroscopy. Application to calmodulin.

Authors:  M Ikura; L E Kay; A Bax
Journal:  Biochemistry       Date:  1990-05-15       Impact factor: 3.162

View more
  80 in total

Review 1.  HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors.

Authors:  Silke Wissing; Nicole L K Galloway; Warner C Greene
Journal:  Mol Aspects Med       Date:  2010-06-09

Review 2.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

3.  Mechanism for APOBEC3G catalytic exclusion of RNA and non-substrate DNA.

Authors:  William C Solomon; Wazo Myint; Shurong Hou; Tapan Kanai; Rashmi Tripathi; Nese Kurt Yilmaz; Celia A Schiffer; Hiroshi Matsuo
Journal:  Nucleic Acids Res       Date:  2019-08-22       Impact factor: 16.971

Review 4.  The current structural and functional understanding of APOBEC deaminases.

Authors:  Ronda Bransteitter; Courtney Prochnow; Xiaojiang S Chen
Journal:  Cell Mol Life Sci       Date:  2009-06-23       Impact factor: 9.261

5.  The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization.

Authors:  Markus-Frederik Bohn; Shivender M D Shandilya; Tania V Silvas; Ellen A Nalivaika; Takahide Kouno; Brian A Kelch; Sean P Ryder; Nese Kurt-Yilmaz; Mohan Somasundaran; Celia A Schiffer
Journal:  Structure       Date:  2015-04-23       Impact factor: 5.006

6.  Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B.

Authors:  Shurong Hou; Tania V Silvas; Florian Leidner; Ellen A Nalivaika; Hiroshi Matsuo; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  J Chem Theory Comput       Date:  2018-12-11       Impact factor: 6.006

7.  Characterization of the Catalytic Domain of Human APOBEC3B and the Critical Structural Role for a Conserved Methionine.

Authors:  Sachini U Siriwardena; Thisari A Guruge; Ashok S Bhagwat
Journal:  J Mol Biol       Date:  2015-08-14       Impact factor: 5.469

8.  A hydrodynamic analysis of APOBEC3G reveals a monomer-dimer-tetramer self-association that has implications for anti-HIV function.

Authors:  Jason D Salter; Jolanta Krucinska; Jay Raina; Harold C Smith; Joseph E Wedekind
Journal:  Biochemistry       Date:  2009-11-17       Impact factor: 3.162

Review 9.  Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.

Authors:  Jessica L Smith; Wei Bu; Ryan C Burdick; Vinay K Pathak
Journal:  Trends Pharmacol Sci       Date:  2009-12       Impact factor: 14.819

10.  Definition of the interacting interfaces of Apobec3G and HIV-1 Vif using MAPPIT mutagenesis analysis.

Authors:  Delphine Lavens; Frank Peelman; José Van der Heyden; Isabel Uyttendaele; Dominiek Catteeuw; Annick Verhee; Bertrand Van Schoubroeck; Julia Kurth; Sabine Hallenberger; Reginald Clayton; Jan Tavernier
Journal:  Nucleic Acids Res       Date:  2009-12-16       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.